Author

G Malik

Observed name: G. Malik

Observed institutions: University of Aberdeen, NHS Grampian, Royal Aberdeen Children's Hospital

ORCID: 0000-0001-9912-2996

Observed ORCID: 0000-0001-9912-2996

OpenAlex ID: A5087060389

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

G135 High dose infliximab in juvenile idiopathic arthritis: a scottish experience

2019 · A Christie, J Davidson, et al.

G451 Juvenile systemic lupus erythematosus(jsle) presenting as idiopathic intracranial hypertension

2018 · G Malik, JE Davidson, et al.

Is the “instant flow” option on the NIOX ® analyser needed?

2006 · G. Malik, S.W. Turner · Medical Engineering & Physics

Works count: 8

Citation count: 97

H-index: 4

I10-index: 3